Statements (31)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:medical_condition
|
| gptkbp:affects |
substantia nigra
|
| gptkbp:alsoKnownAs |
gptkb:Parkinson's_disease
|
| gptkbp:category |
gptkb:neurodegenerative_disease
|
| gptkbp:cause |
gptkb:unknown
|
| gptkbp:complication |
gptkb:dementia
gptkb:depression autonomic dysfunction |
| gptkbp:diagnosedBy |
gptkb:neuroscientist
clinical examination |
| gptkbp:firstDescribed |
gptkb:James_Parkinson
1817 |
| gptkbp:hasBiomarker |
Lewy bodies
|
| gptkbp:ICD-10_code |
gptkb:G20
|
| gptkbp:pathology |
loss of dopaminergic neurons
|
| gptkbp:prevalence |
higher in elderly
|
| gptkbp:progression |
progressive
chronic |
| gptkbp:riskFactor |
age
family history male sex |
| gptkbp:symptom |
bradykinesia
postural instability rigidity tremor |
| gptkbp:treatment |
gptkb:levodopa
MAO-B inhibitors dopamine agonists |
| gptkbp:bfsParent |
gptkb:Primary_Parkinsonism
|
| gptkbp:bfsLayer |
8
|
| https://www.w3.org/2000/01/rdf-schema#label |
idiopathic Parkinsonism
|